SCHEMBL28211106

SCHEMBL28211106

CCC(=O)c1ccc(-c2ccsc2)c([N+](=O)[O-])c1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ERN1 O75460 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ADORA3 P0DMS8 2/20 0.40
▸ ADORA2A P29274 2/20 0.40
▸ ADORA2B P29275 2/20 0.40
▸ ADORA1 P30542 2/20 0.40
▸ EIF4E P06730 1/20 0.39
▸ HCAR3 P49019 7/20 0.39
▸ PDK1 Q15118 1/20 0.39
▸ MAOA P21397 1/20 0.38
▸ MAOB P27338 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ CASP6 P55212 1/20 0.37
▸ MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18458311 0.85 MAPT (0.48) ERN1ALDH1A1MAPK1KMT2ASMN1; SMN2
SCHEMBL18458067 0.84 CASP6 (0.55) ERN1LMNAEIF4EHCAR3TSHR
SCHEMBL13011479 0.82 VCAM1 (0.52) ERN1ALDH1A1LMNAKMT2AMAPT
SCHEMBL11541099 0.81 MAPT (0.53) ALDH1A1LMNAMAPK1HTTKMT2A
SCHEMBL28211105 0.79 MAPT (0.44) ALDH1A1KMT2ASMN1; SMN2ADORA3ADORA2A
SCHEMBL18458068 0.76 POLB (0.56) ALDH1A1LMNAHTTKMT2ASMN1; SMN2
SCHEMBL28858691 0.75 ERN1 (0.38) ERN1ALDH1A1KMT2ASMN1; SMN2EIF4E
SCHEMBL28211111 0.74 ERN1 (0.41) ERN1ALDH1A1SMN1; SMN2EIF4EMAOA
SCHEMBL28211113 0.74 HTT (0.54) ERN1ALDH1A1LMNAMAPK1HTT
SCHEMBL5913395 0.74 ERN1 (0.40) ERN1ALDH1A1KMT2ASMN1; SMN2EIF4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107922375-A Target the antitumoral compounds and its application method of IDH2 mutation 正大天晴药业集团股份有限公司 2018-04-17 — — CN disclosed
Send feedback